Navigation Links
Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
Date:9/16/2008

to fundamentally alter the way in which research on living cells and organisms is conducted," said Dr. David Smoller, President of Sigma-Aldrich's Research Biotech Business Unit. "By refining ZFN production methods and utilizing our established distribution capabilities, Sigma-Aldrich is making this exciting technology available to life science researchers worldwide."

By facilitating the creation of complete gene knockout and knock-in somatic, embryonic and primary cell lines, ZFNs allow researchers to precisely determine the biological function of a gene in more relevant backgrounds. It is anticipated that ZFN-mediated genome editing could be used to generate novel animal models of disease that more closely mimic human disease, as well as providing more realistic data on the potential toxicity of new drug compounds. For biopharmaceutical manufacturers, ZFNs will enable the creation of cell lines with improved growth characteristics, altered glycosylation properties, and other traits resulting in higher yields.

Through its exclusive partnership with Sangamo BioSciences, Inc. (Nasdaq: SGMO), the pioneer in zinc finger nuclease research, Sigma Life Science is the sole source of validated research reagents incorporating ZFN technology. Sigma Life Science employs high-throughput production methods to create customized ZFN reagents for user-specified gene targets in just six to eight weeks. All CompoZr reagents are functionally validated in a cell line appropriate for the intended organism of interest, and customers are provided with full protocols for use of their reagents and troubleshooting support from Sigma Life Science's experienced technical team.

Sigma-Aldrich has invested over $60 million in its Life Science and High Te
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
2. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
3. Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72.
4. Sigma-Aldrich Corporations 2nd Quarter 2008 Earnings Conference Call
5. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
6. Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
7. Sigma-Aldrich Announces Collaboration to Develop Monoclonal Antibodies
8. Sigma-Aldrich Signs Agreement With Plextronics to Distribute Plexcore(R) Organic Electronics Materials
9. Sigma-Aldrich to Present at the Nasdaq 21st Investor Program on Wednesday, May 21, 2008
10. Sigma-Aldrich (Nasdaq: SIAL) CAO & CFO Hogan Plans to Retire; Search for Successor Underway
11. Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... the University of Illinois at Urbana-Champaign have demonstrated ... (pBNAs) can be used like traditional photographic film ... smaller than the wavelength of light (for example, ... A standard optical microscope acts as a "nanocamera" ... "Unlike conventional photographic film, the effect (writing and ...
(Date:7/18/2014)... 18, 2014 Emerging Nuclear Power Countries ... 2030 , Summary , The latest report from GlobalData, ... and Development Analysis to 2030 covers the emerging nuclear ... provides comprehensive information on key market players and their ... in various countries across the world has also been ...
(Date:7/17/2014)... WASHINGTON , July 17, 2014  Vanda Pharmaceuticals ... company focused on the development and commercialization of products ... announced it will release results for the second quarter ... market opens. The Company will host ... August 7, 2014, during which Vanda management will discuss ...
(Date:7/17/2014)... major road blocks to the design and development of ... Researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) ... meaning a theoretical model free of adjustable or ... carriers" in semiconductors. Hot carriers are electrical charge carriers ... than charge carriers at thermal equilibrium. , "Hot carrier ...
Breaking Biology Technology:'Nanocamera' takes pictures at distances smaller than light's own wavelength 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2First ab initio method for characterizing hot carriers 2First ab initio method for characterizing hot carriers 3
... Aureus Pharma, a leading provider of,knowledge management ... release today of the new software solution ... evaluate target, cell and,drug profiles using bio-assays ... Pharma,s AurSCOPE Target Knowledge databases. AurPROFILER has ...
... Inc., the,operating company of WuXi PharmaTech (NYSE: ... of Garry Takle, Ph.D. as Vice President of ... Testing Services for its,Philadelphia facility., (Logo: ... with the company for nine years in roles ...
... HILL, N.C., Aug. 15 The U.S. ... into multiple market,segments. In this challenging marketplace, ... complex organizational and,decision-making structures to effectively represent ... being influenced by medical professionals,focused on efficacy ...
Cached Biology Technology:Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution 2WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2U.S. Hospital Sales Opportunities Maximized Through Functional Optimization 2
(Date:7/21/2014)... developed a pioneering new way using samples of ... of drugs on the heart without using human or ... Dr Helen Maddock an expert in cardiovascular physiology ... and Exercise Sciences and could lead to the ... the quality of their treatments improved. , Adverse effects ...
(Date:7/21/2014)... Boston, MA Scientists at Brigham and Women,s Hospital ... generate fully functional human platelets in vitro. The work ... blood transfusion needs worldwide. , The study is published ... "The ability to generate an alternative source of functional ... paradigm shift in how we collect platelets that may ...
(Date:7/21/2014)... July 21, 2014 Research and Markets ( ... "Next Generation Biometric Market by Technology, Function, ... 2014 - 2020" report to their offering. ... is the verification of humans by their characteristics ... vein, and DNA. DNA and vein recognition are ...
Breaking Biology News(10 mins):New technique uses 'simulated' human heart to screen drugs 2Scientists successfully generate human platelets using next-generation bioreactor 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 3
... reef, the Scken reef in the Koster Fjord, is ... the University of Gothenburg have started a restoration project ... being removed and placed on the Scken reef. ... In Sweden, only one reef-building coral species exists, a ...
... prone to extinction than others? A new study of marine ... million years of fossil data for marine invertebrates reveals that ... hit even when populations are large, the authors report. ... surface. But because monitoring data are harder to collect at ...
... -- Buffalo Grove, Illinois-based specialty-oncology drug development company, Meridian ... Food and Drug Administration (FDA) has granted Meridian,s ... (pre-IND) meeting to discuss its plan to commence ... various cancer indications. The meeting is scheduled for ...
Cached Biology News:Sweden's only coral reef at risk of dying 2Sweden's only coral reef at risk of dying 3Fossil study helps pinpoint extinction risks for ocean animals 2FDA Grants Meridian Laboratories Pre-Ind Meeting for Captisol-Enabled Docetaxel in the Treatment of Cancer 2
... The genus Salmonella is a member of ... Gram-negative bacilli that are facultative and flagellated (motile). ... flagellar antigen (phase 1 & 2), the "O" ... and the "Vi" or capsular antigen (referred to ...
... sequence: H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH 2 ... corresponding peptide and ... 5 I-labelled peptide, please ... and ([ 1 ...
This free-standing laminar flow hood provides a horizontal flow of HEPA-filtered air to create a clean processing area. Air return slots along the front and side edges of the work area enhance system...
...
Biology Products: